Filed: 11/14/2023ACC: 0001104659-23-117496
📋 What this filing means
MV MANAGEMENT XI, L.L.C. filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $60.11M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$60.11M
Total AUM (reported)
9.43M
Total Shares
Allocation by class
COM CL A$54.08M90.0%
CL A$6.03M10.0%
COM CL A NEW$3.8K0.0%
Portfolio Concentration
Top 3$60.11M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 9.43M
Sole
Full voting authority
9.43M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
ROVER GROUP INC
SOLEShares8.64M
TypeSH
Market value$54.08M
89.96%
Sole
8.64M
Shared
0.00
None
0.00
RECURSION PHARMACEUTICALS IN
SOLEShares788.76K
TypeSH
Market value$6.03M
10.04%
Sole
788.76K
Shared
0.00
None
0.00
ANGI INC
SOLEShares1.90K
TypeSH
Market value$3.8K
<0.01%
Sole
1.90K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ROVER GROUP INCSOLE | COM CL A | 8.64M | SH | $54.08M 89.96% | 8.64M | 0.00 | 0.00 |
RECURSION PHARMACEUTICALS INSOLE | CL A | 788.76K | SH | $6.03M 10.04% | 788.76K | 0.00 | 0.00 |
ANGI INCSOLE | COM CL A NEW | 1.90K | SH | $3.8K <0.01% | 1.90K | 0.00 | 0.00 |